In multiple myeloma, the IL-6-triggered STAT3 signaling represents a pivotal oncogenic pathway that acts primarily through regulation of cell survival, rendering multiple myeloma an ideal model system to study STAT3 function5, 6. This evidence concerns the gene IL6 and plasma cell myeloma.